450P Pancreatic exocrine insufficiency (PEI) in patients (pts) with well-differentiated neuroendocrine tumours (wd-NETs) treated with somatostatin analogues (SSAs): incidence and impact on quality of life.
Authors
Lamarca, AngelaMcCallum, Lynne
Nuttall, Christina
Barriuso, Jorge
Frizziero, Melissa
Leon, Rebecca
Mansoor, Was
McNamara, Mairéad G
Hubner, Richard A
Valle, Juan W
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, ManchesterIssue Date
2017-09
Metadata
Show full item recordCitation
450P Pancreatic exocrine insufficiency (PEI) in patients (pts) with well-differentiated neuroendocrine tumours (wd-NETs) treated with somatostatin analogues (SSAs): incidence and impact on quality of life. 2017, 28(suppl_5): Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdx368.022Additional Links
http://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx368.022/4108671/450PPancreatic-exocrine-insufficiency-PEI-inType
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx368.022